Postoperative atrial fibrillation and use of oral anticoagulants after cardiac surgery: A real-life, single-centre study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Postoperative atrial fibrillation (POAF) is the most common complication following cardiac surgery and is associated with significant morbidity. This study sought to provide a comprehensive and contemporary evaluation of the clinical course and management of POAF, with particular emphasis on the use of oral anticoagulants (OACs). This single-centre, retrospective, longitudinal study included patients undergoing cardiac surgery with cardiopulmonary bypass at Skåne University Hospital, Lund, between February 2020 and September 2021. Included patients had no prior history of atrial fibrillation (AF) or atrial flutter and survived to hospital discharge. Patients were excluded if they underwent redo surgery, heart transplantation, hypothermic circulatory arrest or had endocarditis. Data on POAF and OAC use were obtained through retrospective chart review. 1,012 patients were included, of whom 43% developed POAF. Among POAF patients, 8.8% were discharged with ongoing AF. OACs were prescribed to 38% of POAF patients at hospital discharge, with 31% of prescriptions initiated by a cardiothoracic surgeon. The cumulative incidence of documented AF was 7.9% at 3-month follow-up and 8.8% at 1 year. However, 89% of POAF patients remained on OAC therapy at 1-year follow-up, despite the low rates of documented AF recurrence. POAF is frequently observed after cardiac surgery but typically resolves during the early postoperative period. Nonetheless, a substantial proportion of patients were prescribed and remained on long-term OAC therapy despite an absence of documented AF at follow-up and the heightened bleeding risk of this population.
Source: Figshare
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235444422
